Sanofi-aventis Reaches Settlement with Sawai, Takata Seiyaku in Allegra Patent Dispute; Allegra’s Use Patent Validity Established

The generic drug makers Sawai Pharmaceutical and Takata Seiyaku have reached a settlement with sanofi-aventis K.K. in their dispute over the use patent for the anti-allergy drug Allegra (fexofenadine) on July 11. Both companies have withdrawn their lawsuits, resulting in...read more